You just read:

Orexigen Therapeutics Announces Publication of Contrave® (naltrexone HCl and bupropion HCl extended-release tablets) Real-World Study Results in "Obesity"

News provided by

Orexigen Therapeutics, Inc.

Jan 06, 2017, 08:05 ET